CMS Energy shorts hold steady as earnings loom and analysts trim targets

CMS Energy reports third-quarter results on October 27, and the week's most telling development is not in the borrow market but in the analyst community, where target prices have been moving in both directions even as the stock climbed 3.2% on the week to $68.42.

Short interest has stabilised after a sharp build. At 6.1% of the free float, with roughly 18.5 million shares short, the position is up about 20% over the past month but barely moved this week, down less than 1% from Monday's level. The previous note flagged a rapid weekly build; that pace has clearly slowed. The borrow market remains entirely unthreatening: availability is at 1,750%, meaning shares available to borrow far exceed those already borrowed, and cost to borrow is a negligible 0.49%. Availability has tightened from the 2,300%-plus range of two weeks ago, but at this level there is no pressure on existing short positions and no friction for new ones. Options confirm the relaxed tone. The put/call ratio of 0.09 is slightly below its 20-day average of 0.10, and nowhere near the 52-week high of 0.64. The ORTEX short score has nudged up to 44.5 from 43.8 a week ago, still comfortably mid-range.

The more active conversation this week has been among analysts, and the direction of travel is mixed. Morgan Stanley cut its target to $73 from $77 this morning while keeping an Equal-Weight rating, the second reduction from that desk in two months. Barclays trimmed its target sharply to $72 from $81 last Thursday, though it held an Overweight. Truist cut to $77 from $81 the week before. Against that, BMO Capital raised its target to $76 from $73 on Monday, maintaining Outperform. The mean target across the Street is $75.08, about 10% above the current price. The bull case rests on CMS's visible earnings growth, rate relief supporting the regulated utility base, and potential multiple expansion at the NorthStar Clean Energy segment. Bears point to tightening financial conditions, slower rate-base growth at Consumers Energy, and the regulatory risk attached to renewable projects if the Inflation Reduction Act were rolled back. Valuation reflects a company the market is broadly comfortable owning: the price-to-earnings multiple has expanded roughly 0.8 points over the past month to 16.7x, and the price-to-book ratio has moved higher over the same period. The forward earnings growth factor score is in the 95th percentile, the clearest bull signal in the factor set.

CMS is also a candidate for inclusion in the CRSP US Small index at the December 2026 Quarterly Review. ORTEX puts the probability at 28%, with the stock currently 1.5% above the entry price line of $67.39. If it qualifies, index trackers would need to buy roughly $341 million of stock, equivalent to about 1.3 days of normal trading volume. The rank date is December 4, with a potential trade date of December 22. That is a mechanical rather than fundamental flow, and the probability remains well below even odds, but it adds a secondary catalyst to the calendar beyond earnings.

Peers moved broadly with CMS this week. Consolidated Edison rose 3.9% and NiSource gained 3.1%, while DTE Energy added less than 1%. CMS's 3.2% weekly gain is near the top of the peer group, though the gap is not dramatic enough to signal unusual repositioning.

The next meaningful data point is the October 27 earnings call, where the pace of rate-base growth at Consumers Energy and any update on NorthStar Clean Energy's capital programme will determine whether analysts who cut targets this week revisit them upward or continue trimming.